Iron Overload in Allogeneic Hematopoietic Cell Transplantation Outcome: A Meta-Analysis




Philippe Armand, Haesook T. Kim, Johanna M. Virtanen, Riitta K. Parkkola, Maija A. Itälä-Remes, Navneet S. Majhail, Linda J. Burns, Todd DeFor, Bryan Trottier, Uwe Platzbecker, Joseph H. Antin, Martin Wermke

PublisherElsevier Inc.

2014

Biology of Blood and Marrow Transplantation

Biology of Blood and Marrow Transplantation

20

8

1248

1251

4

1523-6536

DOIhttps://doi.org/10.1016/j.bbmt.2014.04.024

http://api.elsevier.com/content/abstract/scopus_id:84904065494



An elevated ferritin level before allogeneic hematopoietic cell transplantation (HCT) is an adverse prognostic factor for overall survival (OS) and nonrelapse mortality. Because ferritin is an imperfect surrogate of iron stores, the prognostic role of iron overload remains unclear. We conducted a patient-level meta-analysis of 4studies that used magnetic resonance imaging to estimate pre-HCT liver iron content (LIC). An elevated LIC was not associated with a significant increase in mortality: the hazard ratio (HR) for mortality associated with LIC>7mg/g dry weight (primary endpoint) was 1.4 (P= .18). In contrast, ferritin >1000ng/mL was a significant prognostic factor (HR for mortality, 1.7; P= .036). There was, however, no significant association between ferritin > 2500 and mortality. This meta-analysis suggests that iron overload, as assessed by LIC, is not a strong prognostic factor for OS in a general adult HCT population. Our data also suggest that ferritin is an inadequate surrogate for iron overload in HCT. © 2014 American Society for Blood and Marrow Transplantation.




Last updated on 2024-26-11 at 11:06